Antidepressant treatment appeared to influence the relationship between fatigue feeling and the biochemical pathways we investigated in our population of lung cancer patients: Patients under antidepressant treatment had lower tryptophan and higher CRP levels than those without this medication, also indicating indirectly that enhanced tryptophan breakdown might be involved in the development of depression. This evidence concerns the gene CRP and major depressive disorder.